Literature DB >> 29971447

Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.

Kang Wang1,2,3, Khalil Ghasemi Falavarjani1,2,4, Muneeswar G Nittala1, Min Sagong5, Charles C Wykoff6, Jano van Hemert7, Michael Ip1,2, SriniVas R Sadda1,2.   

Abstract

Purpose: The purpose of this study was to compare the use of central and montaged ultra-wide-field fluorescein angiography (UWFFA) images for calculating the area of nonperfusion (NP) and ischemic index (ISI) in patients with retinal vein occlusion (RVO) and macular edema (ME) and to correlate these measurements with best-corrected visual acuity (BCVA) and central macular thickness (CMT).
Methods: Thirty eyes of 30 RVO patients with recurrent ME were enrolled. Baseline UWFA images were sent to the Doheny Image Reading Center for quantitative analysis by certified graders. The association between ISI from the various zones and BCVA and CMT was examined by Spearman rank correlation and compared. Generalized linear models (GLMs) were used to analyze associations between BCVA and disease status.
Results: The NP area and ISI for central and montaged images were not significantly different for any retinal zone. A modest but statistically significant negative linear correlation was observed between BCVA and ISI, ranging from r = -0.3825 in the perimacular area (PMA) to r = -0.584 in the far peripheral area (FPA). On GLM analysis, both PMA (β = -1.059; 95% confidence interval: -1.74 to -0.378) and FPA (β = -0.505; 95% confidence interval: -0.988 to -0.021) were significant independent predictors of BCVA. We found no correlation between ISI from the various zones and CMT in this cohort. Conclusions: Montaging of UWFFA images may not be required to adequately quantify and represent areas of NP in eyes with RVO. NP in both the PMA and peripheral retina appear relevant to visual function, highlighting the importance of evaluating the retinal periphery in these individuals.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29971447     DOI: 10.1167/iovs.18-23796

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Quantitative analysis of retinal vasculature in normal eyes using ultra-widefield fluorescein angiography.

Authors:  Jing-Wen Jiang; Zuo-Hui-Zi Yi; Xiao-Ling Wang; Jue-Jun Liu; Gong-Peng Sun; Chang-Zheng Chen
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

2.  Leakage index on ultra-widefield fluorescence angiography in different regions of retina and its correlation with cystoid macular edema in central retinal vein occlusion eyes.

Authors:  Xiaoling Wang; Gongpeng Sun; Zuohuizi Yi; A'min Xu; Lu He; Jingwen Jiang; Hongmei Zheng; Changzheng Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-24       Impact factor: 3.117

3.  Correlation between the Nonperfusion Area on Ultra-Widefield Fluorescein Angiography and Nonflow Area on Optical Coherence Tomographic Angiography in Retinal Vein Occlusion.

Authors:  Jianfeng Huang; Yingyi Lu; Xiaoya Gu; Bodi Zheng; Tong Chen
Journal:  J Ophthalmol       Date:  2021-04-30       Impact factor: 1.909

4.  Relationship between distribution and severity of non-perfusion and cytokine levels and macular thickness in branch retinal vein occlusion.

Authors:  Gahyung Ryu; Donghyoun Noh; Jano van Hemert; SriniVas R Sadda; Min Sagong
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

5.  Effects of refractive power on quantification using ultra-widefield retinal imaging.

Authors:  Su-Ho Lim; Seongyong Jeong; Jang Hwan Ahn; Jano van Hemert; Min Sagong
Journal:  BMC Ophthalmol       Date:  2021-03-20       Impact factor: 2.209

6.  Optical-coherence tomography angiography and ultrawide-field angiography findings in eyes with refractory macular edema secondary to retinal vein occlusion switched to aflibercept: A subanalysis from a 48-week prospective study.

Authors:  Kimberly Spooner; Samantha Fraser-Bell; Thomas Hong; Andrew Chang
Journal:  Taiwan J Ophthalmol       Date:  2020-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.